Genetic Analysis operates in medical technology. The company conducts research and development in the field of diagnostics, with the main focus on the human microbiome. The technology is based on the company's research platform and the products are used, for example, for testing and analysis of bacteria and other viruses. The largest operations are in the Nordic market.

Quotes for Genetic Analysis AS

Right Now

+/-
0.02
%
3,08%
Latest
0.67
High
0.67
Low
0.64
Volume
42 271
Turnover (NOK)
27 416
Market Value (MNOK)
28,2
Time (Latest trade)

Board

CEO

  • Ronny Hermansen

Chairperson of the Board

  • Per Matsson

Board

  • Andrew Stapleton
  • Camilla Huse Bondesson
  • Rune Sørum
  • Staffan Strömberg

Largest Owners

Name Capital % Votes % Date
Bio-Rad Luxembourg S.À.R.L. 22,55 22,55 2023-12-27
Avanza Bank AB 15,30 15,30 2023-12-27
Muen Invest AS 4,27 4,27 2023-12-27
S. Munkhaugen AS 4,15 4,15 2023-12-27
Nordnet Bank AB 3,97 3,97 2023-12-27
Lucellum AS 3,68 3,68 2023-12-27
Biohit Oyj 3,38 3,38 2023-12-27
Ochrino AS 2,98 2,98 2023-12-27
Leif Jørgen Moger 2,81 2,81 2023-12-27
Stella Invest AS 2,51 2,51 2023-12-27

Insider trading

Key Numbers

*Compiled data from Millistream

Upcoming reports

  • 2024-05-29 Delårsrapport 2024-Q1